ORYZON Opens U.S. Operation
The European Epigenetic Company Opens New Office in Cambridge
ORYZON Genomics, announced today that the Company is opening a U.S. operation which will be located at 245 First Street in Cambridge, Massachusetts. After incorporation of its U.S. affiliate, Oryzon Corp, in July 2014, the U.S. arm of Oryzon Genomics is now fully launching its operations in Massachusetts. Oryzon plans to have 15-20% of its total headcount in its U.S. office in the next quarter.
